Document
The following Fermentek substances and their derivatives, are considered "bi-functional" or
"controlled" materials and are therefore forbidden to be exported without an export license:
- Aflatoxins (Aflatoxin B1, Aflatoxin B2, Aflatoxin G1, Aflatoxin G2, Aflatoxin M1, Aflatoxin M2)
- Diacetoxyscirpenol (DAS)
- HT-2 toxin
- T-2 toxin
- Microcystins
To obtain an export license for these substances we (Fermentek) have to submit a request, with your declaration on the intended usage of the materials attached, to the Israeli authorities.
To make the process more efficient, below are some guidelines on how to fill in the required declaration:
There are two available declaration forms (shown below) - an "End-user Declaration" and a "Distributor Declaration".
The title of both declarations is similar, but there are important differences between them. It is mandatory to make sure to fill out the correct form and fill it in according to the instructions (any deviation will cause the request to be rejected).
The main difference between the forms is (apart from the names of the files), the number of sections (11 sections in the End-User form, and 9 sections in the Distributor form). As mentioned, it is mandatory tofill out the correct form.
Who is each form for?
"End-User declaration"
"End-User declaration" is for customers who use the substances for their internal purposes, such as scientific research, analytical test services, or quality control, as well as manufacturers who use the substances in their manufacturing process, even if the final product is intended for distribution.
Therefore, for example, a manufacturer of analytical test kits is considered an "End-User" and should use the End-User Declaration format. In the declaration, it should be stated that the material is to be used in the process of analytical test kit manufacturing.
When filling out the "End-User Declaration" form please note:
1. Do not fill sections 5, 5a, and 5b
2. Section 6a: fill in the number of vials and quantities in each vial (E.g. 2X10mg).
3. Section 9: describe, as detailed as possible, the intended usage in a way that supports the quantities you request.
4. Do not fill and sign section 10
5. Section 11: fill in all the requested details including name, title, signature, date, and company's stamp.
"Distributor Declaration"
"Distributor Declaration" is for customers who buy the substances for stock and intend to sell them to presently unknown end-users and or in which quantities. (When the end-user is known, the "End-User Declaration" should be filled out including sections 5, 5a, 5b, and 10, signed by both, the distributor and the end-user.
In this case, please fill in also the "company details" for both of them)
When filling out the form please note:
1. Section 5a: fill out the number of vials and quantities in each vial (E.g. 2X10mg).
2. Section 8: describe, as detailed as possible, the intended usage of the substances by the end-users.
3. Section 8: fill out the countries to which you intend to sell the substances to. By filling in the name of countries, you commit to selling only to these countries. Generalization, such as Western Europe, EU countries, etc. will not be not accepted.
4. Section 9: fill in all the requested details including name, title, signature, date, and company's stamp.
"Company Details"
Please also fill in your company details in the attached document. These details are required for us to complete the license request. Please state in as much detail as possible, the intended use of the substances, the relevant activities of your company, and why you need them, and add a link to a relevant web page that supports your company’s activities and the need for the substances.
Please send all the completed forms to: [email protected].
Document
Document
